A Study on Kunthiriga Kalimbu(External Medicine) in the management of Padai(Tinea)

Clinical Evaluation of siddha herbal formulation Kunthiriga Kalimbu(External Medicine) in the management of Padai(Tinea) among the outpatients attending the OPD of Ayothidass Pandithar Hospital, National Institute of Siddha. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069006

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Kunthiriga Kalimbu: External application of the medicine 20g for 1 week 2 times a day Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Participants having the signs and symptoms of padai (tinea) (Tinea capitis,Tinea corporis,Tinea cruris,Tinea barbae,Tinea manuum,Tinea pedis,Tinea imbricate,Tinea faciei,Tinea gladiatorum) NRS below 6 points(moderate) and DLQI below 10 score(moderate) will be included

Exclusion criteria

Exclusion criteria: Pregnant or lactating women. Known cases of Skin diseases [contact dermatitis, vitiligo, psoriasis, atopic dermatitis, Tinea unguium].

Design outcomes

Primary

Measure	Time frame
Reduction of NRS and DLQI before after treatmentTimepoint: 2 MONTHS-SCREENING 2 MONTHS-PATIENT ENROLLMENT 2 MONTHS-OUTCOME ASSESSMENT	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactSuruthi Balakrishnan

National Institute of Siddha

drmanjarimd@gmail.com8056903083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026